We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPT
1076
DELISTED
RAPT Therapeutics
RAPT
| $291K | ﹤0.01% |
+1,512
| New | +$286K |
|
1077
Apple Hospitality REIT
APLE
$3.71B
| $290K | ﹤0.01% |
20,613
+1,710
| +9% | +$27.1K |
|
1078
iRadimed
IRMD
$1.12B
| $290K | ﹤0.01% |
9,646
+2,340
| +32% | +$81.5K |
|
1079
Appian
APPN
$2.49B
| $289K | ﹤0.01% |
7,070
-1,203
| -15% | -$58.4K |
|
1080
LendingTree
TREE
$444M
| $288K | ﹤0.01% |
12,080
-3,695
| -23% | -$144K |
|
1081
Air Products & Chemicals
APD
$67.7B
| $287K | ﹤0.01% |
1,234
| – | – |
|
1082
Asana
ASAN
$2.07B
| $287K | ﹤0.01% |
12,922
| – | – |
|
1083
Bruker
BRKR
$9.03B
| $286K | ﹤0.01% |
5,395
-2,357
| -30% | -$141K |
|
1084
Fox Factory Holding Corp
FOXF
$913M
| $286K | ﹤0.01% |
3,613
| – | – |
|
1085
HealthStream
HSTM
$829M
| $286K | ﹤0.01% |
13,450
-800
| -6% | -$18.2K |
|
1086
Scansource
SCSC
$1.06B
| $286K | ﹤0.01% |
10,820
+150
| +1% | +$4.53K |
|
1087
Remitly
RELY
$5.1B
| $285K | ﹤0.01% |
+25,662
| New | +$268K |
|
1088
Evergy
EVRG
$19.2B
| $284K | ﹤0.01% |
4,775
-2,005
| -30% | -$135K |
|
|
MCHB
1089
Mechanics Bancorp
MCHB
$3.8B
| $283K | ﹤0.01% |
9,820
-600
| -6% | -$21.1K |
|
1090
South Plains Financial
SPFI
$858M
| $282K | ﹤0.01% |
10,247
+1,002
| +11% | +$26.1K |
|
1091
Valley National Bancorp
VLY
$8.25B
| $281K | ﹤0.01% |
+26,050
| New | +$300K |
|
|
FBMS
1092
DELISTED
The First Bancshares, Inc.
FBMS
| $280K | ﹤0.01% |
9,358
| – | – |
|
|
TELL
1093
DELISTED
Tellurian Inc.
TELL
| $279K | ﹤0.01% |
116,833
-21,050
| -15% | -$75.9K |
|
1094
CNB Financial Corp
CCNE
$1.03B
| $277K | ﹤0.01% |
+11,768
| New | +$301K |
|
1095
Antero Resources
AR
$11.5B
| $276K | ﹤0.01% |
+9,047
| New | +$334K |
|
|
ACCD
1096
DELISTED
Accolade Inc
ACCD
| $275K | ﹤0.01% |
+24,050
| New | +$262K |
|
1097
Noodles & Co
NDLS
$98M
| $274K | ﹤0.01% |
7,300
+1,297
| +22% | +$51.5K |
|
|
NWLI
1098
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $274K | ﹤0.01% |
1,604
-290
| -15% | -$56.5K |
|
1099
Schrodinger
SDGR
$1.39B
| $273K | ﹤0.01% |
10,921
+1,388
| +15% | +$40.8K |
|
1100
Werner Enterprises
WERN
$2.27B
| $270K | ﹤0.01% |
7,185
-40,319
| -85% | -$1.64M |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.